Low grade tumours tend to have a near-normal karyotype with few genomic rearrangements and often have activating mutations in FGFR3 and the MAPK pathway, whereas high-grade tumours typically have inactivating mutations in TP53 and/or other tumour suppressor genes and multiple chromosomal aberrations [2]. Here, FGFR3 is linked to neoplasm.